Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 4236 | Ordered by Date (descending)
1 2 3 ... 41 42 43  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
GammaDelta Therapeutics Ltd.. (10/16/19). "Press Release: Adaptate Biotherapeutics Formed to Develop Antibody-based Therapies that Modulate Gamma Delta T-cells". London. 2019-10-16
Healx Ltd.. (10/16/19). "Press Release: Healx Secures $56m in Series B Financing, Launches Global Accelerator Programme for Rare Diseases". Cambridge. 2019-10-16
Amarna Therapeutics B.V.. (10/16/19). "Press Release: Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisory Board". Leiden. 2019-10-16
Cell Mogrify Ltd.. (10/14/19). "Press Release: Mogrify Raises Additional $16 Million to Advance Its Mission to Transform the Development of Life-saving Cell Therapies". Cambridge. 2019-10-14
Evotec SE. (10/10/19). "Press Release: Just-Evotec Biologics and Biocon Biologics Sign Licensing Deal for a Biosimilar Asset". Hamburg, Seattle, WA & Bengaluru. 2019-10-10
Bayer AG. (10/10/19). "Press Release: Bayer Launches LifeHub UK Focused on Artificial Intelligence to Optimize Data-driven Drug discovery and Disease Diagnosis". Leverkusen & Reading. 2019-10-10
Agilent Technologies Inc.. (10/9/19). "Press Release: Agilent Opens State-of-the-Art Spectroscopy Site in the UK". Santa Clara, CA. 2019-10-09
N-Side S.A.. (10/9/19). "Press Release: N-Side Welcomes Wade Wirta as US Managing Director". Louvain-la-Neuve. 2019-10-09
Cyclica Inc.. (10/8/19). "Press Release: To Build Stronger Partnerships Globally, Cyclica Appoints Long Time Pharma R&D Leader Vern De Biasi as VP, Global Head of Strategic Partnerships". Toronto. 2019-10-08
GlaxoSmithKline plc. (10/8/19). "Press Release: GSK and Lyell Immunopharma Join Forces to Develop the Next Generation of Cancer Cell Therapies". London & San Francisco, CA. 2019-10-08
4D Pharma plc. (10/8/19). "Press Release: 4D Pharma Collaborates with MSD to Develop Live Biotherapeutics for Vaccines". 2019-10-08
Solentim Ltd.. (10/8/19). "Press Release: Mark Stockdale Joins Solentim in New »Amalgamator of Business and Biology« Position". Bournemouth. 2019-10-08
MiroBio Ltd.. (10/7/19). "Press Release: MiroBio Launches with £27m ($34m) Series A from Leading Life Sciences Investors". Oxford. 2019-10-07
Adaptimmune Ltd.. (10/5/19). "Press Release: United States Orphan Drug Designation for Treatment of Soft Tissue Sarcomas Granted to SPEAR T-cells Targeting MAGE-A4". Philadeliphia, PA & Oxfordshire. 2019-10-05
Genomenon, Inc.. (10/2/19). "Press Release: Congenica Partners with Genomenon to Integrate Mastermind into Congenica Clinical Platform". Ann Arbor, MI. 2019-10-02
N-Side S.A.. (10/1/19). "Press Release: AstraZeneca Selects N-Side Suite for Clinical Trials to Optimize and Monitor Clinical Trial Supply Chain". Louvain-la-Neuve. 2019-10-01
Solentim Ltd.. (10/1/19). "Press Release: Dr Mark Truesdale Joins Solentim as New Chief Marketing Officer". Bournemouth. 2019-10-01
Adaptimmune Ltd.. (10/1/19). "Press Release: Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer". Philadeliphia, PA & Oxfordshire. 2019-10-01
Arctoris Ltd.. (9/30/19). "Press Release: Arctoris Ltd Secures Seed Funding of £3.2 Million to Advance Novel Drug Discovery Platform Powered by Robotics". London. 2019-09-30
Arix Bioscience plc. (9/30/19). "Press Release: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics". London. 2019-09-30
Adaptimmune Ltd.. (9/30/19). "Press Release: Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing Phase 1 Trial with ADP-A2M4 Presented at ESMO". Philadeliphia, PA & Oxfordshire. 2019-09-30
Consilium Strategic Communications Ltd.. (9/26/19). "Press Release: Consilium Strategic Communications Expands International Senior Team with Four New Appointments". London & Boston, MA. 2019-09-26
Fluidic Analytics Ltd.. (9/23/19). "Press Release: Fluidic Analytics Welcomes Dr Joe Keegan as Chairman". 2019-09-23
Innate Pharma S.A.. (9/23/19). "Press Release: Innate Pharma Announces Clinical Data Presentations on IPH5401 and Monalizumab at ESMO 2019". Marseille. 2019-09-23
Oncimmune Holdings plc. (9/20/19). "Press Release: €8.5m Credit Facility Secured. Funding to Accelerate the Further Commercialisation of Oncimmune’s Lead Products and Services". 2019-09-20
PredictImmune Ltd.. (9/19/19). "Press Release: PredictImmune Announces New ‘Framework Agreement’ with Cambridge Enterprise". Cambridge. 2019-09-19
Divide & Conquer. (9/18/19). "Press Release: Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature". Cambridge. 2019-09-18
BenevolentAI Ltd.. (9/17/19). "Press Release: BenevolentAI Announces $90 Million Investment from Temasek". London. 2019-09-17
Procarta Biosystems Ltd.. (9/17/19). "Press Release: Procarta Receives CARB-X Award of up to $9.2 million". Stevenage. 2019-09-17
AC Immune S.A.. (9/17/19). "Press Release: AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620". Lausanne. 2019-09-17
UCL Technology Fund. (9/16/19). "Press Release: Echopoint Raises £2.8m to Address the ‘Grey Zone’ of Heart Disease treatment". 2019-09-16
PPF Group N.V.. (9/16/19). "Press Release: PPF Expands Its Investment in the Healthcare Sector through Acquisition of Significant Stake in T Cell Therapy Company Autolus Therapeutics". 2019-09-16
Avalon Ventures. (9/11/19). "Press Release: Avalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari Pharmaceuticals by GSK". San Diego, CA. 2019-09-11
o2h Discovery. (9/11/19). "Press Release: Cedilla Therapeutics and o2h Discovery Are Pleased to Announce Multi FTE Expansion to Their Synthetic Chemistry Collaboration". Cambridge & Cambridge, MA. 2019-09-11
UK Biobank. (9/11/19). "Press Release: UK Biobank Leads the Way in Genetics Research to Tackle Chronic Diseases". 2019-09-11
Kiadis Pharma N.V.. (9/10/19). "Press Release: Kiadis Pharma Announces Results for the Six Months Ended June 30, 2019". Amsterdam. 2019-09-10
Cell Mogrify Ltd.. (9/9/19). "Press Release: Mogrify Appoints Dr. Jane Osbourn, OBE as Chair". Cambridge. 2019-09-09
BioAscent Discovery Ltd.. (9/9/19). "Press Release: BioAscent Expands into US Market, Appoints Julian Abery to Spearhead Growth". Newhouse. 2019-09-09
4BIO Capital (4BIO Ventures Management Ltd.). (9/9/19). "Press Release: 4BIO Capital Raises $50 million in First Close of New Advanced Therapies Fund". London & Boston, MA. 2019-09-09
Lightcast Discovery Ltd.. (9/9/19). "Press Release: Lightcast Discovery Raises £1.3m in Seed Financing to Expand Pilot Studies". Cambridge. 2019-09-09
Owlstone Medical Ltd.. (9/5/19). "Press Release: Owlstone Medical Announces Advancements in Breath Biopsy Platform Including Launch of Next Generation ReCIVA Breath Sampler and CASPER Portable Air Supply". Cambridge. 2019-09-05
Theragnostics Ltd.. (9/5/19). "Press Release: Theragnostics Signs Agreement with AstraZeneca". London. 2019-09-05
Achilles Therapeutics. (9/3/19). "Press Release: Achilles Therapeutics Raises £100 Million in Oversubscribed Series B Financing". Stevenage. 2019-09-03
Orbit Discovery Ltd.. (8/30/19). "Press Release: Mario Polywka Joins Orbit Discovery’s Board of Directors". Oxford. 2019-08-30
BioCity Group Ltd.. (8/29/19). "Press Release: BioCity Invests in Early-stage Precision Medicine Biotech Kinomica". Cheshire. 2019-08-29
Unibio International plc. (8/28/19). "Press Release: Unibio Completes USD 15 M (GBP 12.4 M) Financing Round". London & Copenhagen. 2019-08-28
Vaccitech Ltd.. (8/27/19). "Press Release: Vaccitech Appoints Bill Enright as New Chief Executive Officer". Philadeliphia, PA & Oxfordshire. 2019-08-27
Adaptimmune Therapeutics plc. (8/27/19). "Press Release: Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products Expressing IL-7 and CCL19 as a Next-generation Treatment for Cancer Patients". Philadeliphia, PA & Oxfordshire. 2019-08-27
GlaxoSmithKline plc. (8/23/19). "Press Release: GSK Announces Positive Headline Results from the Pivotal DREAMM-2 Study for Multiple MMyeloma". London. 2019-08-23
AstraZeneca plc. (8/22/19). "Press Release: Roxadustat Approved in China for the Treatment of Anaemia in Non-dialysis-dependent Patients with Chronic Kidney Disease". 2019-08-22
AstraZeneca plc. (8/22/19). "Press Release: AstraZeneca Agrees to Buy US FDA Priority Review Voucher from Sobi". 2019-08-22
GlaxoSmithKline plc. (8/22/19). "Press Release: ViiV Healthcare Reports Positive Phase III Study Results of Investigational, Long-acting, Injectable HIV-treatment Regimen Administered every Two Months". London. 2019-08-22
Rexgenero. (8/21/19). "Press Release: Atelerix Consortium Awarded £267,000 Innovate UK Grant for Collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies". London. 2019-08-21
AstraZeneca plc. (8/21/19). "Press Release: Update on the Phase III NEPTUNE Trial of Imfinzi plus Tremelimumab in Stage IV Non-small Cell Lung Cancer". 2019-08-21
GlaxoSmithKline plc. (8/21/19). "Press Release: GSK Submits First Regulatory Application for Daprodustat in Japan for Patients with Renal Anaemia Due to Chronic Kidney Disease". London. 2019-08-21
Medicines and Healthcare Products Regulatory Agency (MHRA). (8/20/19). "Press Release: Dr June Raine to Become Interim Chief Executive Officer". 2019-08-20
AstraZeneca plc. (8/20/19). "Press Release: Farxiga Met Primary Endpoint in Landmark Phase III DAPA-HF Trial for the Treatment of Patients with Heart Failure". 2019-08-20
Nabriva Therapeutics plc. (8/19/19). "Press Release: Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP)". Dublin. 2019-08-19
Juvenescence Ltd.. (8/19/19). "Press Release: Juvenescence Closes $100 Million Series B Round, Plans Follow On and Incremental Investments in Longevity Drug Development". Tortola, British Virgin Islands. 2019-08-19
Nabriva Therapeutics plc. (8/16/19). "Press Release: Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. 2019-08-16
University College London (UCL). (8/13/19). "Press Release: Biotech Startup Secures £6.5m for Dementia Research". 2019-08-13
Synpromics Ltd.. (8/13/19). "Press Release: AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio". Research Triangle Park, NC. 2019-08-13
Jazz Pharmaceuticals plc. (8/12/19). "Press Release: Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.". Dublin. 2019-08-12
GlaxoSmithKline plc. (8/12/19). "Press Release: GSK Announces Leadership Changes in the US". Philadeliphia, PA. 2019-08-12
Genomics Medicine Ireland Ltd.. (8/12/19). "Press Release: Genomics Medicine Ireland Announces Strategic Advisory Board". 2019-08-12
Circassia Pharmaceuticals plc. (8/12/19). "Press Release: Circassia Appoints Industry Veteran Jonathan Emms as Chief Operating Officer". Oxford. 2019-08-12
Start Codon Ltd.. (8/9/19). "Press Release: Start Codon Partners with Clustermarket and Science Entrepreneur Club to Support Life Science and Healthcare Start-ups". Cambridge. 2019-08-09
Bicycle Therapeutics plc. (8/8/19). "Press Release: Bicycle Therapeutics Reports Second Quarter 2019 Financial Results and Provides Clinical Update". Cambridge & Boston, MA. 2019-08-08
MeiraGTx Holdings plc. (8/8/19). "Press Release: MeiraGTx Announces Pricing of Public Offering of Ordinary Shares". London & New York, NY. 2019-08-08
IMBA – Institute of Molecular Biotechnology GmbH. (8/7/19). "Press Release: a:head bio – Launched to Transform CNS Drug Discovery". 2019-08-07
MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY. 2019-08-07
MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Announces Proposed Public Offering of Ordinary Shares". London & New York, NY. 2019-08-07
TopiVert Pharma Ltd.. (8/7/19). "Press Release: TopiVert Announces Top-Line Results from THEIA-1 Phase 2b/3 Clinical Study of TOP1630 as a Treatment for Dry Eye Disease". London. 2019-08-07
BioLineRx Ltd.. (8/6/19). "Press Release: BioLineRx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". Tel Aviv. 2019-08-06
Expedeon AG. (8/6/19). "Press Release: Expedeon AG Signs Commercial Agreement with Sona Nanotech". Halifax, Heidelberg & Cambridge. 2019-08-06
Allogene Therapeutics, Inc.. (8/5/19). "Press Release: Allogene Therapeutics Appoints Rafael G. Amado, M.D. as Executive Vice President of Research and Development and Chief Medical Officer". South San Francisco, CA. 2019-08-05
Sosei Group Corporation (d/b/a Sosei Heptares). (8/5/19). "Press Release: Sosei Heptares and Takeda Enter into New Strategic Multi-target Research, Development and Commercialization Partnership". Tokyo & London. 2019-08-05
Exscientia Ltd.. (8/5/19). "Press Release: Sanofi Exercises Option on Exscientia-designed Bispecific Small Molecule for Treatment of Immunological Conditions". 2019-08-05
Silence Therapeutics plc. (8/5/19). "Press Release: Silence Therapeutics Appoints Jørgen Wittendorff as Head of Manufacturing". London. 2019-08-05
Adaptimmune Therapeutics plc. (8/1/19). "Press Release: Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update". Philadeliphia, PA & Oxfordshire. 2019-08-01
Adaptimmune Therapeutics plc. (8/1/19). "Press Release: New Executive Team Announced at Adaptimmune. Adrian Rawcliffe to Assume CEO role from September 1, 2019". Philadeliphia, PA & Oxfordshire. 2019-08-01
Sensyne Health plc. (7/31/19). "Press Release: Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Development of New Treatments for Cardiovascular Disease Using Clinical Artificial Intelligence". 2019-07-31
Atlantic Healthcare plc. (7/31/19). "Press Release: Atlantic Healthcare Announces Results from Phase 3 Trial of Alicaforsen Enema for Orphan-Designated Pouchitis". Cambridge. 2019-07-31
PredictImmune Ltd.. (7/30/19). "Press Release: PredictImmune Closes Series B Funding Round, Raising £10M to Further Accelerate Global Commercial Expansion and Support Expanding Product Pipeline". Cambridge. 2019-07-30
Quanta Dialysis Technologies Ltd.. (7/29/19). "Press Release: Quanta Raises $48 million in Series C Funding Round". Alcester, Warwickshire. 2019-07-29
Adaptimmune Therapeutics plc. (7/25/19). "Press Release: Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS". Philadeliphia, PA & Oxfordshire. 2019-07-25
Open Pharma Research Ltd.. (7/23/19). "Press Release: Lab of the Future Congress, 13-14th November 2019, Cambridge UK". Cambridge. 2019-07-23
Exscientia Ltd.. (7/23/19). "Press Release: Exscientia Enters Broad Rare Disease Drug Discovery Collaboration with Rallybio". 2019-07-23
Adaptimmune Therapeutics plc. (7/22/19). "Press Release: Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center". Philadeliphia, PA & Oxfordshire. 2019-07-22
Medicxi Ventures. (7/19/19). "Press Release: Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters". London, Geneva & Jersey. 2019-07-19
Silence Therapeutics plc. (7/18/19). "Press Release: Silence Therapeutics and Mallinckrodt Announce Collaboration to Develop and Commercialize RNAi Therapeutics for Complement-mediated Diseases". London & Staines-upon-Thames. 2019-07-18
Adaptimmune Therapeutics plc. (7/18/19). "Press Release: Adaptimmune Starts the SURPASS Clinical Trial with Its First Next-Generation SPEAR T-cells Targeting MAGE-A4 to Enhance Antitumor Responses". Philadeliphia, PA & Oxfordshire. 2019-07-18
Boehringer Ingelheim. (7/18/19). "Press Release: INMARK Results Suggest Prompt Treatment of IPF with Antifibrotics to Slow Disease Progression". Ingelheim. 2019-07-18
Silence Therapeutics plc. (7/18/19). "Press Release: Mallinckrodt to Make an Equity Investment in Silence Therapeutics as Part of a Collaboration". London & Staines-upon-Thames. 2019-07-18
Arcis Biotechnology Ltd.. (7/16/19). "Press Release: Arcis Biotechnology and Mirnax Biosens Sign Exclusive License Agreement for Arcis Sample Prep Technology". Daresbury & Madrid. 2019-07-16
Sosei Group Corporation (d/b/a Sosei Heptares). (7/16/19). "Press Release: Sosei Heptares Enters into Multi-target Research Collaboration and License Agreement with Genentech". Tokyo & London. 2019-07-16
Illumina, Inc.. (7/16/19). "Press Release: Illumina Expands Genomics Accelerator to Cambridge, UK". San Diego, CA. 2019-07-16
Recursion Pharmaceuticals, Inc.. (7/15/19). "Press Release: Recursion Pharmaceuticals Secures $121 Million in Series C Financing". Salt Lake City, UT. 2019-07-15
Healx Ltd.. (7/11/19). "Press Release: Dr Neil Thompson Appointed CSO of Healx to Spearhead Drug Discovery Expansion". 2019-07-11
Consilium Strategic Communications Ltd.. (7/10/19). "Press Release: Consilium Strategic Communications Sponsors Future of Healthcare Investor Forum 2019 at London Stock Exchange". London. 2019-07-10
1 2 3 ... 41 42 43  next pagenext page



Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px

» top